These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27299502)

  • 1. Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.
    Bhateja P; Ward MC; Hunter GH; Greskovich JF; Reddy CA; Nwizu TI; Lamarre E; Burkey BB; Adelstein DJ; Koyfman SA
    Head Neck; 2016 Dec; 38(12):1832-1836. PubMed ID: 27299502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
    Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
    J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma.
    McCoul ED; Har-El G
    Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):479-86. PubMed ID: 19451470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Microsurgery Versus Radiotherapy Versus Open Partial Laryngectomy for T2 Laryngeal Carcinoma: A Systematic Review of Oncological Outcomes.
    Campo F; Zocchi J; Ralli M; De Seta D; Russo FY; Angeletti D; Minni A; Greco A; Pellini R; de Vincentiis M
    Ear Nose Throat J; 2021 Feb; 100(1_suppl):51S-58S. PubMed ID: 32511005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of extension and impaired mobility in cancer of the vocal cord.
    Van den Bogaert W; Ostyn F; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):181-4. PubMed ID: 6833020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.
    Kitani Y; Kubota A; Furukawa M; Sato K
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1011-7. PubMed ID: 25726168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.
    Beyaert S; Hamoir M; Van Maanen A; Grégoire V; Schmitz S
    Eur J Surg Oncol; 2019 Jul; 45(7):1188-1195. PubMed ID: 30940421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
    Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control.
    Akimoto T; Nonaka T; Kitamoto Y; Ishikawa H; Ninomiya H; Chikamatsu K; Furuya N; Hayakawa K; Mitsuhashi N; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):995-1001. PubMed ID: 16406396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone.
    Ljumanovic R; Langendijk JA; van Wattingen M; Schenk B; Knol DL; Leemans CR; Castelijns JA
    Radiology; 2007 Jul; 244(1):205-12. PubMed ID: 17581903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.
    Turesson I; Sandberg N; Mercke C; Johansson KA; Sandin I; Wallgren A
    Acta Oncol; 1991; 30(3):357-62. PubMed ID: 2036247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in T2 glottic cancer.
    Harwood AR; DeBoer G
    Cancer; 1980 Mar; 45(5):991-5. PubMed ID: 7260851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
    Khan MK; Koyfman SA; Hunter GK; Reddy CA; Saxton JP
    Radiat Oncol; 2012 Nov; 7():193. PubMed ID: 23164282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
    Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
    Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.
    Peng Z; Li Y; Jin L; Tao X; Cai X; Feng J; Liu R; Zhang Q; Li L
    Photodiagnosis Photodyn Ther; 2016 Sep; 15():167-71. PubMed ID: 27378675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.
    Lim YJ; Wu HG; Kwon TK; Hah JH; Sung MW; Kim KH; Park CI
    Cancer Res Treat; 2015 Oct; 47(4):862-70. PubMed ID: 25687859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management for stage II glottic carcinoma: radiation therapy or surgery.
    Chatani M; Yoshinobu M; Masaki N; Yoshino K
    Strahlenther Onkol; 1996 Dec; 172(12):664-8. PubMed ID: 8972751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent hyperfractionated radiotherapy and carboplatin with transoral debulking microsurgery for T2N0 glottic cancer.
    Ohguri T; Imada H; Nakano K; Yahara K; Udaka T; Suzuki H; Korogi Y
    Head Neck; 2008 Aug; 30(8):1027-34. PubMed ID: 18302271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of S-1 to radiotherapy for treatment of T2N0 glottic cancer: Results of the multiple-center retrospective cohort study in Japan with a propensity score analysis.
    Sano D; Tanabe T; Kubota A; Miyamoto S; Tanigaki Y; Okami K; Komatsu M; Ikoma R; Suzuki K; Akazawa Y; Kobayashi S; Yamada Y; Oridate N
    Oral Oncol; 2019 Dec; 99():104454. PubMed ID: 31675682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment, comorbidity and survival in stage III laryngeal cancer.
    Connor KL; Pattle S; Kerr GR; Junor E
    Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.